Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | CA12 | O43570 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | CA3 | P07451 | 1/20 | 0.33 |
| ▸ | CA4 | P22748 | 1/20 | 0.33 |
| ▸ | CA6 | P23280 | 1/20 | 0.33 |
| ▸ | CA5A | P35218 | 1/20 | 0.33 |
| ▸ | CA7 | P43166 | 1/20 | 0.33 |
| ▸ | CA9 | Q16790 | 1/20 | 0.33 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.33 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.33 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | APEX1 | P27695 | 1/20 | 0.31 |
| ▸ | BLM | P54132 | 1/20 | 0.31 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.30 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.30 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL563377 | 0.81 | MAPT (0.43) | MAPTLMNACA12CA1CA2 | |
| SCHEMBL10239611 | 0.78 | CA1 (0.53) | MAPTLMNACA12CA1CA2 | |
| SCHEMBL563231 | 0.78 | CA1 (0.53) | MAPTLMNACA12CA1CA2 | |
| SCHEMBL3751829 | 0.71 | MAPT (0.57) | MAPTLMNAKMT2ACHRM2CHRM4 | |
| SCHEMBL26075213 | 0.71 | MAPT (0.57) | MAPTLMNAKMT2ACHRM2CHRM4 | |
| SCHEMBL19262494 | 0.71 | MAPT (0.57) | MAPTLMNAKMT2ACHRM2CHRM4 | |
| SCHEMBL18821137 | 0.66 | TSHR (0.48) | MAPTKMT2ACHRM2CHRM4CHRM5 | |
| SCHEMBL26790454 | 0.66 | L3MBTL1 (0.39) | MAPTKMT2ACHRM2CHRM4CHRM5 | |
| SCHEMBL26790459 | 0.66 | L3MBTL1 (0.39) | MAPTKMT2ACHRM2CHRM4CHRM5 | |
| SCHEMBL2617930 | 0.66 | MEN1 (0.34) | MAPTKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11673862-B2 | Processes to produce brivaracetam | SUZHOU PENGXU PHARMATECH CO. LTD. (CN) | 2023-06-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11673862-B2 | Processes to produce brivaracetam | BLVRB, CYP3A4, POR | MAPT 1149/4885LMNA 3886/4885CA12 2526/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.